RETRACTED ARTICLE: Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level

Anjing Gong, Na Ge, Weicheng Yao, Luxiang Lu, Hui Liang

DOI: 10.1007/s00280-014-2534-5
Published: 2014-07-22
Container: Cancer Chemotherapy and Pharmacology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00280-014-2534-5,
  title = {RETRACTED ARTICLE: Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level},
  author = {Anjing Gong and Na Ge and Weicheng Yao and Luxiang Lu and Hui Liang},
  year = {2014},
  journal = {Cancer Chemotherapy and Pharmacology},
  doi = {10.1007/s00280-014-2534-5},
  url = {https://doi.org/10.1007/s00280-014-2534-5}
}

RIS

TY  - JOUR
TI  - RETRACTED ARTICLE: Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level
AU  - Anjing Gong
AU  - Na Ge
AU  - Weicheng Yao
AU  - Luxiang Lu
AU  - Hui Liang
PY  - 2014
JO  - Cancer Chemotherapy and Pharmacology
DO  - 10.1007/s00280-014-2534-5
UR  - https://doi.org/10.1007/s00280-014-2534-5
ER  -

APA

Gong, A., Ge, N., Yao, W., Lu, L., & Liang, H. (2014). RETRACTED ARTICLE: Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-014-2534-5

Source records

crossref · retrieved 2026-11-10T21:48:00.762Z